Toxins, pathogenic infection (viral and bacterial), and physical injury to the liver results in a loss of hepatic tissue, triggering a regenerative response to restore liver cell mass. Dysregulation in the repair process can lead to liver failure or liver cancer. The aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor functionally identified with proliferative processes. The AhR ligand 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) the prototype for a class of compounds responsible for a range of toxic or adaptive endpoints, inhibits liver regeneration following tissue injury thus implicating the AhR in liver repair. Our long-term goal is to understand mechanistically how the AhR contributes to liver homeostasis by regulating cell proliferation, and thereby identify the molecular basis for TCDD-induced disruption of normal biological processes. We hypothesize that the AhR plays an important role in liver homeostasis, in part by regulating progress through G1 phase of the cell cycle in proliferating hepatocytes. The goal of this proposal is to examine the functional relationship between AhR activity and TCDD responsiveness proteins known to regulate hepatocyte proliferation. Specifically, the planned studies will examine the molecular basis and relative contribution of cyclin-dependent kinase 2 (CDK2) inhibition and plasminogen activator inhibitor-1 (PAI-1) expression on liver regeneration. TCDD alters CDK2 activity and PAI-1 expression during liver regeneration, representing distinct intracellular and extracellular (autocrine or paracrine) mechanisms of action that conspire to inhibit the restorative response to injury. Preliminary results also demonstrate that AhR regulation of the PAI-1 gene involves a novel (non-XRE) DNA element that will be characterized in detail. The proposed studies are an extension of currently funded research looking at the AhR in regulating hepatic proliferation in cell culture models, and seeks to build on previous findings using a physiologically relevant (non-transformed) model of cell proliferation. Parallels between humans and mice in the regenerative response, instills confidence that findings generated during these studies will be directly applicable to the human condition. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Research Project (R01)
Project #
2R01ES007800-11
Application #
7213823
Study Section
Special Emphasis Panel (ZRG1-DIG-F (02))
Program Officer
Heindel, Jerrold
Project Start
1996-03-01
Project End
2011-10-31
Budget Start
2006-12-01
Budget End
2007-10-31
Support Year
11
Fiscal Year
2007
Total Cost
$339,750
Indirect Cost
Name
University of Texas Medical Br Galveston
Department
Pharmacology
Type
Schools of Medicine
DUNS #
800771149
City
Galveston
State
TX
Country
United States
Zip Code
77555
Joshi, Aditya D; Mustafa, Mehnaz G; Lichti, Cheryl F et al. (2015) Homocitrullination Is a Novel Histone H1 Epigenetic Mark Dependent on Aryl Hydrocarbon Receptor Recruitment of Carbamoyl Phosphate Synthase 1. J Biol Chem 290:27767-78
Joshi, Aditya D; Carter, Dwayne E; Harper Jr, Tod A et al. (2015) Aryl hydrocarbon receptor-dependent stanniocalcin 2 induction by cinnabarinic acid provides cytoprotection against endoplasmic reticulum and oxidative stress. J Pharmacol Exp Ther 353:201-12
Jackson, Daniel P; Li, Hui; Mitchell, Kristen A et al. (2014) Ah receptor-mediated suppression of liver regeneration through NC-XRE-driven p21Cip1 expression. Mol Pharmacol 85:533-41
Mustafa, Mehnaz G; Petersen, John R; Ju, Hyunsu et al. (2013) Biomarker discovery for early detection of hepatocellular carcinoma in hepatitis C-infected patients. Mol Cell Proteomics 12:3640-52
Wilson, Shelly R; Joshi, Aditya D; Elferink, Cornelis J (2013) The tumor suppressor Kruppel-like factor 6 is a novel aryl hydrocarbon receptor DNA binding partner. J Pharmacol Exp Ther 345:419-29
Huang, Gengming; Elferink, Cornelis J (2012) A novel nonconsensus xenobiotic response element capable of mediating aryl hydrocarbon receptor-dependent gene expression. Mol Pharmacol 81:338-47
Mitchell, Kristen A; Wilson, Shelly R; Elferink, Cornelis J (2010) The activated aryl hydrocarbon receptor synergizes mitogen-induced murine liver hyperplasia. Toxicology 276:103-9
Mitchell, Kristen A; Elferink, Cornelis J (2009) Timing is everything: consequences of transient and sustained AhR activity. Biochem Pharmacol 77:947-56
Szaniszlo, Peter; Rose, William A; Wang, Nan et al. (2006) Scanning cytometry with a LEAP: laser-enabled analysis and processing of live cells in situ. Cytometry A 69:641-51
Mitchell, Kristen A; Lockhart, Courtney A; Huang, Gengming et al. (2006) Sustained aryl hydrocarbon receptor activity attenuates liver regeneration. Mol Pharmacol 70:163-70

Showing the most recent 10 out of 14 publications